University of Miami Health System

Articles

Expanding the Patient Pool for Immunotherapies

March 8th 2024

Although immune checkpoint inhibitors can yield dramatic results and give some patients many years of life, some patients do not yield benefit.

New Compound Takes Aim at CLL

March 4th 2024

Patients with chronic lymphocytic leukemia and related blood cancers are often prescribed targeted drugs called BTK inhibitors.

Damian Green, MD, to Lead Transplantation and Cellular Therapy

February 29th 2024

The blood cancer expert comes to Sylvester Comprehensive Cancer Center after leading the discovery and testing of several immunotherapy approaches.

Sylvester Cancer Researcher and Technology Innovator Named Fellow of the National Academy of Inventors

January 6th 2024

Shanta Dhar, PhD, assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center, has been named a fellow of the National Academy of Inventors.

Sylvester Physician Elected to Society for Neuro-Oncology Board of Directors

December 4th 2023

Macarena de la Fuente, MD, becomes the first Hispanic elected and will represent neurology on the multidisciplinary board.

Dolphins Challenge Cancer and AutoNation Team Up to Tackle Breast Cancer Disparities

November 30th 2023

Dolphins Challenge Cancer and AutoNation are teaming up to address the links between social, economic and environmental factors and breast cancer mortality.

Dr Stephen D. Nimer Named Researcher of the Year

October 30th 2023

BioFlorida, a statewide association for Florida’s life sciences industry, has named Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, “Researcher of the Year.”

New Research Shows Whole Genome Sequencing Provides Extensive Insights into Hodgkin Lymphoma

March 1st 2023

A large research project found that whole genome sequencing can provide much more information about classic Hodgkin lymphoma than exome sequencing, which reads only protein-coding genes.

Sylvester Attracts World’s Top Epigenetics Experts for Fifth Biennial Miami Epigenetics and Cancer Symposium

December 19th 2022

Top epigenetics researchers from around the world gathered in South Beach for the Fifth Biennial Miami Epigenetics and Cancer Symposium, hosted by Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

Sylvester Celebrates Inaugural Cancer Survivorship Symposium

December 6th 2022

More than 160 attendees took part in a day of learning and collaboration as Sylvester Comprehensive Cancer Center hosted the inaugural Cancer Survivorship Symposium.

Sylvester Scientists Discover a New Therapeutic Target to Treat Deadly Breast Cancer

November 22nd 2022

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that a protein complex that governs gene expression sometimes gets rewired during breast cancer to help estrogen receptor positive tumors resist endocrine therapies and become more aggressive.

Dr. Antonio Iavarone Is Committed to Changing How We Treat Brain Tumors

November 2nd 2022

Antonio Iavarone, MD, has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more.

Sylvester Pancreatic Cancer Researcher Dr. Nagaraj Nagathihalli Awarded Florida Department of Health Grant

October 21st 2022

The Florida Department of Health has awarded Nagaraj Nagathihalli, PhD, an associate professor at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, a $583,200 grant to study tobacco risk, tumor progression, and therapeutic options for pancreatic cancer.

Sylvester Researcher Aims for Early Detection of Ovarian Cancer with Support from $500,000 Philanthropic Gift

October 18th 2022

Sophia George, PhD, is hoping to find new strategies for early detection of ovarian cancer, a disease that is particularly deadly for African American, Caribbean, and Jewish women.

$1.8 Million NIH Grant Supports Head and Neck Cancer Research

October 5th 2022

Sylvester Comprehensive Cancer Center researchers Lluis Morey, PhD, and Ramiro Verdun, PhD, have received a $1.8 million NIH R01 grant to study the epigenetic mechanisms that drive head and neck cancers.

Scott M. Welford, PhD, Named Sylvester’s Tumor Biology Research Program Co-leader

September 29th 2022

Scott M. Welford, Ph.D., is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

Woman’s Cancer Association Celebrates Researchers and Award Grants for 2021-2022

August 5th 2022

What began as a small community effort seven decades ago has resulted in a new series of grants to accelerate groundbreaking research at Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine.

Study Finds Wide Variations in Prostate Cancer Risk Within Hispanic Subgroups

June 17th 2022

Research underscores the need to subdivide Hispanics and other racial and ethnic groups to fully understand actual disparities.

Finding the Underlying Mutations Driving CAR-T Failure

May 17th 2022

New research illuminates the mechanisms that make B-cell lymphomas resistant to important immunotherapy

Precision Medicine Advances in Cancer Treatment Highlighted at Inaugural Sylvester Conference

May 13th 2022

Innovative advances in personalized care, immunotherapy, and targeted treatment for people with many types of cancer were the focus of the inaugural Miami Precision Medicine Conference, held April 2 at the Ritz-Carlton in Fort Lauderdale.